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A B S T R A C T
Previous studies have shown an association between low concentration of serum cholesterol, as well as high concen-
tration of serum cortisol, in suicide behavior. The aim of this study was to evaluate whether men after a violent suicide
attempts have different serum cholesterol and cortisol concentrations than those who attempted suicide by non-violent
methods. Venous blood samples were collected within 24 hours of admission, to study concentrations of serum choles-
terol and cortisol. The sample consisted of 31 male subjects suffering from schizophrenia, admitted in a general hospi-
tal after suicide attempt, and was compared with 15 schizophrenic nonsuicidal male controls. Patients with a violent
suicidal attempt were found to have significantly lower cholesterol levels and significantly higher cortisol level than
patients with non-violent attempts and the control subjects. Our findings suggest that suicide attempts should not be
considered a homogenous group. The hypothesis of an association of violent suicidal attempts and peripheral biologi-
cal markers (cholesterol and cortisol) was supported by our findings.
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Introduction
Individuals with schizophrenia are at increased risk
for suicide attempts and completed suicide1–2. Suicide is
the most common cause of death in schizophrenia, there
is a 10% lifetime risk3–4. Various studies aimed at iden-
tifying possible peripheral markers that may be helpful
in the early detection of suicidal behavior have been car-
ried out. Among the most recent hypotheses5–6, low
blood cholesterol level has been extensively explored.
Indeed, since the first report of an unexplained rise in
suicides and other violent deaths observed in several
clinical trials in coronary heart disease designed to
lower plasma cholesterol7–8, a number of studies have
been convergent in observing an association between
low cholesterol and heightened rates of death from sui-
cide and violence. Atmaca9, found that patients with
suicide attempts had significantly lower cholesterol lev-
els than controls. Patients admitted to an emergency
room following a suicide attempt were found to have
lower cholesterol levels than controls10, while in a sepa-
rate study11, the severity of a suicide attempt was in-
versely correlated with serum cholesterol levels. Mo-
dai12, found that patients who had attempted suicide
had lower serum cholesterol level than non-suicidal pa-
tients. Patients with low serum cholesterol levels found
to be twice as likely to have ever made a medically seri-
ous suicide attempt than men with levels above 25th
percentile13, while patients who survived a violent sui-
cide attempts were found to have lower cholesterol lev-
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els than patients who survived a non-violent suicide
attempts14 or controls15. A number of reports also sug-
gest a relationship between the degree of suicidal idea-
tion and the degree of hypocholesterolemia. Papassoti-
ropoulos16 reported that degree of suicidal ideation in
psychiatric inpatients was inversely related to their
cholesterol levels, while Sullivan17 reported a similar
finding in outpatients with major depressive disorder.
There are also reports of low cholesterol levels among
parasuicidal patients18–20.
The investigation of biological correlates of suicidal
behavior is important to identifing high-risk subjects
and developing strategies of prophylaxis. Preventing
suicide is one of the main targets of care.
A role of the stress hormone (as cortisol) in the etiol-
ogy of suicide is evident21, although the mechanisms are
uncertain. Functional interactions of CRH with seroto-
nergic neurons in the midline raphe are suggested expe-
rimentally22 but have not been established in humans.
Still in question is the neuroanatomical basis for pre-
sumed humoral and neural mechanisms of interaction.
The aim of the present study is to provide whether
there are any differences in serum concentration of cho-
lesterol and cortisol between violent and non-violent
suicide attempters, suffered from schizophrenia.
Subjects and Methods
The study used a case-control design to compare the
cholesterol and cortisol levels of men who had a non-vio-
lent (N = 15) and violent (N = 16) suicide attempts and
nonsuicidal male subjects (N = 15). All included subjects
(N = 46) met diagnosis of schizophrenia (ICD-10, Inter-
national Statistical Classification of Diseases and Re-
lated Health Problems = F 20). Table 1 summarizes the
demographic data of the studied subjects and controls.
Inclusion and exclusion criteria
We included in the study only those individuals
whose biochemical analyses from the time of admission
were available (during the period between January 1st
2003 and July 1st 2003). None of the subjects and con-
trols included in the study had used cholesterol-lower-
ing drugs before blood drawing. Patients suffering from
hypertension, hypothyroidism, diabetes mellitus, disor-
ders of lipoprotein metabolism, diagnosis of substance
abuse, including alcoholism, eating disorders and orga-
nic brain syndrome were also excluded from the study.
Subjects
We identified all men, admitted to the Department of
Psychiatry, Clinical Hospital Center Zagreb, during the
period of six months, following a suicide attempt and
suffering from schizophrenia (N=31). Only self-destruc-
tive acts with lethal intent were classified as suicide at-
tempts.
Violent suicidal attempts (N=16) were cutting wounds
(N=8), hanging (N=4), drowning (N=2) and jumping
from heights (N=2).
Overdoses by medicaments (mostly benzodiazepines,
N=14) were considered non-violent (N=15).
The control group consisted of 15 randomly selected
men suffering from schizophrenia (ICD-10, F 20) with
no history of suicide. They met the same criteria as the
study subjects.
All together, 46 patients had enough data to be in-
cluded in the study. The psychiatric diagnoses of the all
included patients were schizophrenia, F 20 – according
to ICD 10.
Statistical analysis
Analysis of covariance (ANCOVA) with age and BMI
as covariates was used to analyze differences in choles-
terol levels between 3 observed groups. Analysis of vari-
ance (ANOVA) were used to analyze differences in corti-
sol levels between 3 observed groups, also age and body
mass indeks (BMI) differences between groups.
A p value of <0.01 was considered to denote the pres-
ence of a statistically significant difference. We used Chi
square test and Fisher’s exact test to analyze differ-
ences in sociodemographic variables between groups.
The Scheffé test was used as a post-hoc test to compare
violence suicide subjects, non-violence suicide subjects
and the control group. All statistical analyses were per-
formed with SPSS version 10 for Windows.
Measures
We included in the study those patients whose fol-
lowing biochemical analyses from the time of admission
were available: serum cortisol (at the morning) and to-
tal cholesterol concentration. Body mass index (BMI)
was a marker of dietary habits. Blood samples were col-
lected from all subjects at 7 am after overnight fasting.
Serum concentrations for cholesterol were determined
enzymatically, immediately after blood collection. The
assays were done with commercial kits (Olympus Diag-
nostic GmbH, Hamburg, Germany) on Olympus AU 600
automatic analyzer. For the in vitro quantitative mea-
surement of cortisol in human serum was used vitros
immunodiagnostic products – cortisol reagent pack
(Johnson-Johnson company).
Results
The sixteen violent suicide attempters, 15 non-vio-
lent suicide attempters and 15 control subjects were in-
cluded in the study. There were no significant differ-
ences across the three analyzed groups of schizophre-
nics for age, body mass index, marital, family and em-
ployment status (Table 1).
Table 2 summarizes the mean±SD serum cholesterol
concentrations and morning cortisol concentrations in
non-violent, violent suicide atempters, and in control group
of schizophrenic patients (without suicide attempts).
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In analyses controlling for age and BMI, the serum
cholesterol concentration was found to be significantly
lower (F –17.35; p<0.01) in the group of violent suicide
attempters (3.87 ± 0.63 mmol/L, N=16) than in the
groups of non-violent suicide attempters (4.79 ± 0.67
mmol/L, N=15) or control subjects (5.55 ± 1.06 mmol/L,
N=15).
For post-hoc testing, we used the Scheffé test and a
significant difference (p<0.01) in cholesterol levels was
revealed between the group of violent and non-violent
suicide attempters. A significant difference (p<0.01) be-
tween the group of violent suicide attempters and con-
trols was found, while no significant difference (p<0.01)
was found between the non-violent suicide attempters
group and controls.
The adjusted means of cholesterol levels for the vio-
lent, non-violent and control groups are shown in Fig-
ure 1.
Using analyses of variances, the serum cortisol con-
centration (morning values) was found to be signifi-
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TABLE 1







Age (years; mean±SD)* 26.53 ± 4.29 26.56 ± 4.72 26.33 ± 4.64
BMI (kg/m2; mean±SD)** 25.01 ± 1.10 25.13 ± 1.87 25.19 ± 1.13
Marital status, N (%)H
Single 9 (60) 10 (62.5) 8 (53.3)
Married 6 (40) 6 (37.5) 5 (53.3)
Divorced 0 (0) 0 (0) 2 (13.3)
Family status, N (%)I
Living alone 5 (33.3) 8 (50) 7 (46.7)
Living with family 10 (66.7) 8 (50) 8 (53.3)
Employment status, N (%)'
Employed 4 (26.7) 4 (25) 4 (26.7)
Unemployed 5 (33.3) 6 (37.5) 5 (33.3)
Retired 1 (6.7) 1 (6.3) 1 (6.7)
High school 1 (6.7) 1 (6.3) 0 (0)
Student 4 (26.7) 4 (25) 5 (33.3)
*F=0.01, p=0.99; **F=0.06, p=0.94; HFisher’s exact test=3.01, p=0.58; Ix2=0.97, df=2, p=0.62; 'Fisher’s exact test=2.15, p=1.00
TABLE 2
CONCENTRATIONS OF SERUM CHOLESTEROL (MEAN±SD) AND MORNING CORTISOL (MEAN±SD) IN NON-VIOLENT,







F value p value
Cholesterol (mmol/L) 4.79 ± 0.67 3.87 ± 0.63* 5.55 ± 1.06 17.35** <0.01
Cortisol (nmol/L) 402.33 ±153.32 682.12 ±161.30* 326.66 ± 96.77 26.49 <0.01
* significantly different from non-violent and control group (post-hoc Scheffe test, p<0.01);


















Fig. 1. Adjusted means of cholesterol (mmol/l).
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cantly higher (F –26.49; p<0.01) in the group of violent
suicide attempters (682.12 ±161.30 nmol/L, N=16) than
in the groups of non-violent suicide attempters (402.33
±153.32 nmol/L, N=15) or control subjects (326.66 ±
96.77 nmol/L, N=15). No significant difference (p<0.01)
was found between the non-violent suicide attempters
group and controls.
Boxplots of serum morning cortisol levels (nmol/l) in
three observed groups are shown in Figure 2.
Discussion
Primary finding of this study is that male schizo-
phrenic patients with violent suicide attempts have sig-
nificantly lower cholesterol level and significantly hi-
gher cortisol level than patients with non-violent suici-
dal attempts. This supports the earlier hypothesis23
that low or lowered serum cholesterol may be associated
with low lipid microviscosity in the brain-cell-mem-
brane and may decrease the exposure of serotonin re-
ceptors on the membrane surface, resulting in decrea-
sed serotonergic receptor function as a whole. Conse-
quently, serotonergic neurotransmission may be inhib-
ited, which may lead to poorer suppression of impulsive
or aggressive behavior or to a depressive state, trigger-
ing a more violent pattern of behavior in susceptible in-
dividuals.
Our findings suggest that suicidal attempts are not a
homogenous group. Men with a history of violent suicide
attempts, which are associated with a higher level of
impulsivity, had lower cholesterol levels. This is consis-
tent with the postulated role of cholesterol in impulsive
behavior24.
Golier13 reported that male patient with low choles-
terol levels were mre likely to have made a serious at-
tempt at suicide compared with those with higher cho-
lesterol levels. Howewer, Apter25 founded that serum
cholesterol levels were significantly higher in adoles-
cent patients who were considered to be at high risk of
suicide compared with their low-risk counterparts.
Several different mechanisms have been suggested
to describe the potential effect of low cholesterol levels
on suicidality. Hawton26 have speculated on the influ-
ence of decreased serotonergic transmission on suicidal
behavior. Steegmans27 described lower plasma seroto-
nin concentrations in men with persistently low serum
cholesterol concentrations.
Terao28 have reported on the possibility that serum
cholesterol levels are positively associated with seroto-
nergic function via cortisol and prolactin responses to
meta-chloro-phenylpiperazine (M-CPP) neuroendocrine
challenges. It support the hypotheses that reduced cho-
lesterol levels result in reduced central serotonin trans-
mission. In contrast, neither prolactin nor cortisol re-
sponse to d-fenfluramine was found to correlate signi-
ficantly with serum cholesterol levels in another stu-
dy29. The existence of inverse correlation between se-
rum cholesterol level and the level of violence of suicide
attempts in our study suggest strongly that low choles-
terol is a risk indicator for suicidal behaviour.
The results from this study suggest furthermore that
violent suicide attempts are associated with higher level
of cortisol in addition to overactivity in the hypotha-
lamic-pituitary-adrenal (HPA) axis. Our finding is in
keeping the results from a previous study30 demonstrat-
ing higher cortisol plasma levels in violent suicide at-
tempters when compared to non-violent attempters.
Hypersecretion of cortisol is strongly implicated in the
pathophysiology of mental disorders and suicide31–32 by
diminished capacity of the dorsal raphe to synthesize
serotonin, and excessive noradrenergic activity of the lo-
cus coeruleus33–34.
In conclusion, the present study supports the previ-
ous reports that low serum cholesterol and also high
cortisol are associated with violent suicide attempts.
These results suggest that low serum cholesterol and
high serum cortisol in patients with psychosis might be
a useful biological markers of suicide risk. Further in-
vestigations are necessary to elucidate the biological
mechanisms of these findings.
















Fig. 2. Boxplots of serum morning cortisol (nmol/l)
concentrations in three observed groups.
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POSTOJE LI RAZLIKE SERUMSKE KONCENTRACIJE KOLESTEROLA I KORTIZOLA ME\U
NASILNIM I NENASILNIM SHIZOFRENIM MU[KARCIMA KOJI POKU[AJU SAMOUBOJSTVO
S A @ E T A K
Neke od ranijih studija pokazuju povezanost niskih vrijednosti serumskog kolesterola i visokih vrijednosti serum-
skog kortizola i suicidalnog pona{anja. Cilj ispitivanja bio je ustanoviti postoje li razlike u serumskih koncentracija-
ma kolesterola i kortizola izme|u pacijenata nakon nasilnih poku{aja suicida u odnosu na pacijente koji su imali
nenasilni poku{aj suicida. Va|enje krvi obavljeno je unutar 24 sata od prijema, kako bi se odredile koncentracije
serumskog kolesterola i kortizola. Uzorak se sastojao od 31 pacijenta sa shizofrenijom, hospitaliziranih u op}oj bolnici
nakon poku{aja suicida, te su uspore|eni s kontrolnom skupinom od 15 nesuicidalnih shizofrenih pacijanata. Usta-
novili smo kako pacijenti nakon nasilnih poku{aja suicida imaju signifikantno ni`e vrijednosti kolesterola i signifi-
kantno vi{e vrijednosti kortizola u odnosu na skupinu nakon nenasilnih poku{aja suicida i kontrolnu skupinu. Na{i
rezultati ukazuju na to kako suicidalni poku{aji ne mogu biti razmatrani kao homogena skupina. Hipoteza poveza-
nosti nasilnih suicidalnih poku{aja i perifernih biolo{kih pokazatelja (kolesterol i kortizol) je potvr|ena u na{em
ispitivanju.
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